RxDoctor Payments Data

Joseph Burns, MD

Sports Medicine · Alpharetta, GANPI 1457347874

Payments from drug & device makers

What this record shows

The money is spread across several categories — other (55.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Linvatec Corporation accounts for 75.4% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2022 at $176,021 and has fallen 72.4% since, to $48,502 in 2025. Among sports medicine clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$375,602in general payments, 2019–2025

Across 159 payments — averaging $2362.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Linvatec Corporation$283K
  • Biorez, Inc.$60K
  • Medical Device Business Services, Inc.$16K
  • Arthrex$6K
  • Johnson & Johnson$2K
  • Depuy Synthes Products, Inc.$2K
  • plus $5K from 15 others

What the payments were for

  • Consulting fees$144,34038%
  • Speaking & faculty fees$4,0001%
  • Travel & lodging$9,8713%
  • Food & beverage$5,3101%
  • Education$4,1111%
  • Gifts$1610%
  • Other$207,80955%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$375,602 in reported general payments places this provider in the 95th percentile of 168 sports medicine providers in Georgia.

See all sports medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$129,737
Medicare patients
236
Services billed
980

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl66$286
Ibuprofen94$229
Methocarbamol55$200
Methylprednisolone19$132
Naproxen52$118
Meloxicam41$73
Tramadol Hcl15$24

Paid to pharmacies, not to this prescriber.

Other sports medicine in Alpharetta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →